Note: Ingredients listed on restricted chemical lists
EC/CAS
204-402-9/120-51-4
Name of the chemical
Benzyl benzoate
Concentration
70-80
EC/CAS
202-086-7/91-64-5
Name of the chemical
2H-1-Benzopyran-2-one
Concentration
2-5
EC/CAS
204-881-4/128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
1-2
EC/CAS
203-213-9/104-55-2
Name of the chemical
Cinnamaldehyde/3-phenyl-propen-2-al
Concentration
1-2
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
.1-1
EC/CAS
203-109-3/103-41-3
Name of the chemical
2-Propenoic acid, 3-phenyl-, phenylmethyl ester
Concentration
N/A
EC/CAS
202-589-1/97-53-0
Name of the chemical
eugenol
Concentration
N/A
General Information
Revision date
2021-02-15
Product name
Vanilla Crunch
1.2.1 Relevant identified uses
Fragrance oil for scenting wax products
supplier name
whicksnwhacks
Manufacturer Name
whicksnwhacks
Emergency telephone
07885 985850
Icons in SDS
Company Information
company name
whicksnwhacks
e-mail address of the competent person responsible for the Safety Data Sheet
whicksnwhacks@hotmail.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317, H319, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
2.1 Classification of the substance or mixture
Regulation (EC) No. 1272/2008 (CLP) Acute Tox. 4 :Harmful if swallowed. Aquatic Chronic 2 :Toxic to aquatic life with long lasting effects. Eye Irrit. 2 :Causes serious eye irritation. Skin Sens. 1 :May cause an allergic skin reaction.
2.2 Label elements
According to Regulation (EC) No. 1272/2008 (CLP) Product Name Vanilla Crunch
Hazard pictograms
GHS07 GHS09
Signal word
Warning
Hazard statements
H302: Harmful if swallowed. H317: May cause an allergic skin reaction. H319: Causes serious eye irritation. H411: Toxic to aquatic life with long lasting effects.
Precautionary statements
None.
2.3 Other hazards
None known.
Additional information
For full text of H/P Statements see section 16.
